METAPROTERENOL SULFATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for metaproterenol sulfate and what is the scope of patent protection?

Metaproterenol sulfate is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, Muro, Chartwell, Cosette, G And W Labs Inc, Morton Grove, Am Therap, Heritage Pharma, Strides Pharma, Usl Pharma, and Watson Labs, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for metaproterenol sulfate.

Summary for METAPROTERENOL SULFATE

US Patents:	0
Tradenames:	3
Applicants:	17
NDAs:	36
Drug Master File Entries:	5
Raw Ingredient (Bulk) Api Vendors:	58
Patent Applications:	2,557
What excipients (inactive ingredients) are in METAPROTERENOL SULFATE?	METAPROTERENOL SULFATE excipients list
DailyMed Link:	METAPROTERENOL SULFATE at DailyMed

Medical Subject Heading (MeSH) Categories for METAPROTERENOL SULFATE

Adrenergic beta-2 Receptor Agonists
Bronchodilator Agents
Sympathomimetics
Tocolytic Agents

US Patents and Regulatory Information for METAPROTERENOL SULFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dey	METAPROTERENOL SULFATE	metaproterenol sulfate	SOLUTION;INHALATION	070805-001	Aug 17, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	METAPROTERENOL SULFATE	metaproterenol sulfate	TABLET;ORAL	073013-001	Jan 31, 1991		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for METAPROTERENOL SULFATE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	AEROSOL, METERED;INHALATION	016402-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SYRUP;ORAL	017571-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.